No Data
Stocks that moved the day before part 1 INTLOOP, Sakura Saku, ANYCOLOR, ETC.
Stock name <code> Closing price on the 13th ⇒ Change from the previous day. Jellybeans <3070> 113 +5 announced a partial change (expansion) in the Shareholder preferential treatment system. Daiko Tsusan <7673> 1340 +101 upwardly revised the second quarter performance estimates. INTLOOP <9556> 6200 +790 the first quarter operating profit is 2.8 times higher than the same period last year. Spider Plus <4192> 384 +34 introduced a Shareholder preferential treatment system. Hatena <3930> 1000 +7625 performance estimates for the fiscal year ending July.
Rakusuru, Kamakura Shinsho, Oji HD, etc.
Seibu HD (9024) rose significantly by 89 to 3199. A basic agreement was signed regarding the liquidity of Tokyo Garden TELUS Kioicho, along with revisions to financial estimates and dividends, and the announcement of a share buyback. The operating profit estimate for the fiscal year ending March 2025 has been raised from the previous estimate of 45 billion yen to 289 billion yen, and the annual dividend has also been increased from the previously planned 30 yen to 40 yen. Additionally, a share buyback of 28 million shares, accounting for 8.66% of the issued shares, with a maximum limit of 70 billion yen was announced. The direction is considered priced in, focusing on shareholder returns.
Stocks that moved or were traded in the first half of the session.
*Raksul <4384> 1310 +204 Significant profit increase in the first quarter and the implementation of a Share Buyback are viewed positively. *Oji Holdings <3861> 614.2 +56.1 The announcement of a large-scale Share Buyback is well received. *Bandai Namco Holdings <7832> 3551 +209 'ELDEN RING NIGHTREIGN' will be released worldwide simultaneously in 2025. *Anycolor <5032> 2546 +142 Positive outlook continues for the first half financial results. *Mitsui High-tec <696
Cell Source - Significant drop, viewed negatively due to performance landing below expectations in the previous period.
Cellsource <4880> has significantly declined. The company announced its financial results for the fiscal year ending October 2024 the previous day. The operating profit is 0.13 billion yen, a decrease of 89.4% compared to the previous period, which is significantly below the previous estimate of 0.42 billion yen. Regarding the contract services for processing synovial-derived stem cells, it has been determined that achieving the anticipated sales is difficult, and a provision for a contract loss of 273 million yen has been recorded. From the fiscal year ending October 2025, the company will transition to consolidated financial statements, and an operating profit of 0.37 billion yen is expected, but there is concern about the failure to meet the previous period's performance.
December 13 [Today's investment strategy]
[FISCO Selected Stock]【Material Stock】Raksul <4384> 1106 yen (12/12) operates a printing and advertising sharing platform called "Raksul." The first quarter financial results have been announced. The operating profit is 0.972 billion yen (up 79.7% year-on-year). The operating profit for the fiscal year ending July 2025 is estimated to be between 3.2 billion and 3.7 billion yen (up 26.8% to 46.6% compared to the previous term). Additionally, a Share Buyback will be implemented, with a maximum of 0.7 million shares corresponding to 1.20% of the outstanding Stock, amounting to 0.7 billion yen.
Pay attention to Rakusuru and Seibu HD, while Cell Source and Seer Inc may be weak.
In the US stock market on the 12th, the Dow Jones Industrial Average fell by 234.44 points to 43,914.12, the Nasdaq Composite Index decreased by 132.05 points to 19,902.84, and the Chicago Nikkei 225 Futures dropped 145 yen compared to the Osaka daytime to 39,665 yen. The exchange rate is 1 dollar = 152.60-70 yen. In today's Tokyo market, Raksul <4384> announced a Share Buyback with a limit of 1.20% of outstanding shares due to an operating profit increase of 79.7% in the first quarter and the sale of "Tokyo Garden TELUS Kioicho" and performance forecasts.